G8865 – Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)

Long description

Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)

Short description

Doc med reas no pneumococcal

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

M5B Specialist - psychiatry

Added

January 1, 2012

Last change

January 1, 2012 – No change

Nearby G codes

• G8857 – Patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)
• G8858 – Referral to a physician for an otologic evaluation not performed, reason not given
• G8859 – Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
• G8860 – Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
• G8861 – Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed
• G8862 – Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
• G8863 – Patients not assessed for risk of bone loss, reason not given
• G8864 – Pneumococcal vaccine administered or previously received
• G8866 – Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)
• G8867 – Pneumococcal vaccine not administered or previously received, reason not given
• G8868 – Patients receiving a first course of anti-tnf therapy
• G8869 – Patient has documented immunity to hepatitis b and initiating anti-tnf therapy
• G8870 – Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy
• G8871 – Patient not receiving a first course of anti-tnf therapy
• G8872 – Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
• G8873 – Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)